Depth and Timing of Improvement of Response for Multiple Myeloma Patients on Lenalidomide Maintenance after Autologous Hematopoietic Stem Cell Transplantation (Auto HCT)
Year: 2017
Type: article
Abstract: Introduction: Lenalidomide maintenance (LM) starting between 2-3 months after auto HCT until progression is our standard of care for multiple myeloma (MM) patients. We aimed to determine the time to best response and the progression free survival (PFS) impact of improving response on LM.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2589430646